Literature DB >> 10524402

Finding our sensitive patients.

T A Buchholz.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10524402     DOI： 10.1016/s0360-3016(99)00255-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  4 in total

1.  Radio-induced apoptosis of peripheral blood CD8 T lymphocytes is a novel prognostic factor for survival in cervical carcinoma patients.

Authors:  R Ordoñez; L A Henríquez-Hernández; M Federico; A Valenciano; B Pinar; M Lloret; E Bordón; C Rodríguez-Gallego; P C Lara
Journal:  Strahlenther Onkol       Date:  2013-12-22       Impact factor: 3.621

2.  Prediction of clinical toxicity in localized cervical carcinoma by radio-induced apoptosis study in peripheral blood lymphocytes (PBLs).

Authors:  Elisa Bordón; Luis Alberto Henríquez Hernández; Pedro C Lara; Beatriz Pinar; Fausto Fontes; Carlos Rodríguez Gallego; Marta Lloret
Journal:  Radiat Oncol       Date:  2009-11-26       Impact factor: 3.481

3.  Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs).

Authors:  Elisa Bordón; Luis Alberto Henríquez-Hernández; Pedro C Lara; Ana Ruíz; Beatriz Pinar; Carlos Rodríguez-Gallego; Marta Lloret
Journal:  Radiat Oncol       Date:  2010-01-28       Impact factor: 3.481

4.  Polymorphisms in DNA-repair genes in a cohort of prostate cancer patients from different areas in Spain: heterogeneity between populations as a confounding factor in association studies.

Authors:  Luis Alberto Henríquez-Hernández; Almudena Valenciano; Palmira Foro-Arnalot; María Jesús Alvarez-Cubero; José Manuel Cozar; José Francisco Suárez-Novo; Manel Castells-Esteve; Adriana Ayala-Gil; Pablo Fernández-Gonzalo; Montse Ferrer; Ferrán Guedea; Gemma Sancho-Pardo; Jordi Craven-Bartle; María José Ortiz-Gordillo; Patricia Cabrera-Roldán; Estefanía Herrera-Ramos; Pedro C Lara
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.